ArticlePhysical activity and nutrition2025
Seven-day supplementation with piceatannol does not improve endothelial function at rest or after exercise: a pilot study.
Article in Physical activity and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposePiceatannol, a polyphenolic compound found in high concentrations in passion fruit, has been reported to exert multiple physiological effects in preclinical studies, including vascular relaxation and increased expression of endothelial nitric oxide synthase. Despite these findings, its influence on endothelial function in humans, both at rest and in response to exercise, remains largely unknown. Therefore, this study aimed to investigate whether a 7-day regimen of piceatannol supplementation alters endothelial function at rest and following low-intensity aerobic exercise.
methodsEight young, healthy men participated in a randomized, double-blind, crossover trial. Each participant completed two experimental conditions: (1) a placebo trial and (2) a piceatannol trial. For seven consecutive days, they ingested tablets containing either 0 mg (placebo) or 10 mg of piceatannol daily. On the morning of the eighth day (8:00 am), they visited the laboratory for baseline assessments, followed by 60 minutes of cycling exercise at 30% of their maximal oxygen uptake. Blood pressure and brachial artery flow-mediated dilation (FMD) were measured before and after exercise.
resultsNo between-trial differences were observed in blood pressure at rest, during exercise, or after exercise. %FMD and absolute FMD likewise did not differ between the placebo and piceatannol trials. The observed effects were small (partial η² ≈ 0.05-0.06), and analysis of covariance adjusting for baseline diameter or shear rate area under the curve yielded consistent results.
conclusionSeven-day piceatannol supplementation did not enhance endothelial function at rest or after low-intensity aerobic exercise in young, healthy men.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.